Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02189876 · ClinicalTrials.gov registry record · NA

Females of African American Legacy Empowering Self (FemAALES)

A NA study of HIV, sponsored by Charles Drew University of Medicine and Science.

Completed
Registry status
NA
Development phase
256
Enrollment target
2
Study locations

NCT02189876: Completed NA study of HIV, sponsored by Charles Drew University of Medicine and Science.

NCT02189876 is a NA study of HIV that has completed, run by Charles Drew University of Medicine and Science. The registered enrollment target is 256 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02189876, a NA study of HIV, has completed, sponsored by Charles Drew University of Medicine and Science.

COMPLETED
Registry status
NA
Development phase
256 participants
Enrollment target
2
Study locations

Study Summary

The FemAALES Project is a community collaborative two-arm intervention designed to prevent HIV (human immunodeficiency) and STD (sexually transmitted disease) infection and transmission among African American women and men by reducing sexual risk factors and enhancing sexual negotiation skills. The team of investigators is a collaboration of researchers and community service providers who are committed to developing prevention interventions that employ holistic and culturally relevant approaches. This includes recognizing the impact of forces such as racism, sexism, and gender expectations on individual behavior and relationship dynamics in African American communities. Specifically, the investigators hypothesis is that compared to the control condition the FemAALES intervention arm will reduce risky sexual behavior and STI (sexually transmitted infection) incidence and will increase condom self-efficacy and risk behavior communication with sexual partners.

Primary Outcome

Determine the impact of the FemAALES intervention compared to the control condition on the number of vaginal and anal sex partners in the prior 90 days .

Conditions Studied

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL FemAALES

Study Locations (2)

California

  • St. John's Well Child and Family Center - Los Angeles
  • Charles Drew University of Medicine and Science - Los Angeles

Trial Details

FieldValue
Enrollment Target 256 participants
Start Date 2013-07
Est. Completion 2018-04
Phase NA

What the finished NCT02189876 record still lists

NCT02189876 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower).

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT02189876 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02189876 about?

NCT02189876 is a clinical study titled "Females of African American Legacy Empowering Self (FemAALES)". The FemAALES Project is a community collaborative two-arm intervention designed to prevent HIV (human immunodeficiency) and STD (sexually transmitted disease) infection and transmission among African American women and men by reducing sexual risk factors and enhancing sexual negotiation skills. The ...

What is the current status of trial NCT02189876?

This trial is currently completed. It is a NA study. The enrollment target is 256 participants. The study started on 2013-07. Estimated completion is 2018-04.

What conditions does trial NCT02189876 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT02189876?

The interventions under investigation include: Standard of Care (BEHAVIORAL), FemAALES (BEHAVIORAL).

Who is sponsoring clinical trial NCT02189876?

This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02189876 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02189876's enrollment target sits among peer trials

256 81st of 303 higher than 219 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02464696 · 256 participants · NA

    Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

  • NCT03793062 · 256 participants

    Genetic and Epigenetic Basis of Chronic Wounds

  • NCT04322318 · 256 participants · Phase 2

    A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • NCT04468360 · 256 participants · Phase 2

    Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02189876, the US trial registry maintained by the National Library of Medicine. NCT02189876 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.